Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.51%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 3.44Close
$ 1.06 - $ 6.77 52-Week Range
Ticker Information
Ticker
CPIXCompany Name
CUMBERLAND PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQCUMBERLAND PHARMACEUTICALS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CPIX - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 633.98K | 1.51% | $ 42.07M |
| 3/31/2025 | $ 650.78K | 1.58% | $ 41.08M |
| 12/31/2024 | $ 605.51K | 1.6% | $ 37.87M |
| 9/30/2024 | $ 561.04K | 1.53% | $ 36.79M |
| 6/30/2024 | $ 533.75K | 1.41% | $ 37.79M |
| 3/31/2024 | $ 600.03K | 1.55% | $ 38.83M |
| 12/31/2023 | $ 667.86K | 1.69% | $ 39.55M |
| 9/30/2023 | $ 668.52K | 1.7% | $ 39.32M |
| 6/30/2023 | $ 707.78K | 1.74% | $ 40.65M |
| 3/31/2023 | $ 652.77K | 1.63% | $ 40.06M |
Key Performance Insights, Last 5 Years
- CUMBERLAND PHARMACEUTICALS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0.63%.
- Over the past 5 years, CUMBERLAND PHARMACEUTICALS INC's average Int. Exp. % has been 1.13%.
- The median Int. Exp. % for CUMBERLAND PHARMACEUTICALS INC during this period was 1.4%
- CUMBERLAND PHARMACEUTICALS INC reached its highest Int. Exp. % over the past 5 years at 1.74%.
- The lowest Int. Exp. % recorded by CUMBERLAND PHARMACEUTICALS INC in the same timeframe 0.27%
CUMBERLAND PHARMACEUTICALS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for CUMBERLAND PHARMACEUTICALS INC is calculated as follows: Int. Exp. [ $ 256.93K ] / Revenues [ $ 40.86M ]
(=) Int. Exp. % [ 0.63% ] CPIX - Interest Expense Margin, Last 5 years
0.27%
Minimum
Dec 31, 2021
1.74%
Maximum
Jun 30, 2023
1.13%
Average
1.4%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |